Catalog: | C0168A |
Product Type: | Antibody |
Reactivity: | H,M,R |
Analysis mode: | IHC |
Host: | Rabbit |
Clonality: | Polyclonal |
Isotype: | IgG |
Concentration: | 1 mg/mL |
Storage: | -20℃ |
Buffer: | PBS with 0.05% Proclin300,and 50% glycerol, pH7.3 |
Purification method: | Affinity purification |
Application: | Signal Transduction, Stem Cells, Cancer, Metabolism |
Conjugation: | Unconjugated |
Immunogen: | TGFB2 |
Swiss port: | P27090 |
Genn_ID: | 21808 |
Celluar localization: | Extracellular matrix, Secreted |
This gene encodes a member of the transforming growth factor β (TGFB) cytokine family, a multifunctional peptide that regulates proliferation, differentiation, adhesion, migration, and other functions in many cell types by transducing signals through transmembrane receptors type I and II Type combination (TGFBR1 and TGFBR2) and its downstream effector, SMAD protein. Disruption of the TGFB/SMAD pathway is associated with a variety of human cancers. The encoded protein secretes and inhibits the growth of interleukin-2 dependent t cells. The t(1, 7)(q41, p21) shift between this gene and HDAC9 is related to Peters abnormality, which is a congenital defect of the anterior chamber of the eye. Knockout mice lacking this gene show perinatal mortality and a series of developmental defects, including heart defects.
Copyright © 2024 Creative Biogene. All rights reserved.